In a study of GBM patients of unknown IDH status, OS was previously found to be greater in those with PsP than in patients who did not develop contrast enhancement.14 Therefore, we sought to examine the difference in OS between these 2 groups in IDH mutant glioma using KM analysis. This evidence concerns the gene IDH2 and central nervous system cancer.